Kingdon Capital is a venture debt provider. Team members are concentrated in New York, United States. Among the 9 companies in the known portfolio are Jasper Therapeutics, Shoreline Biosciences, Imago BioSciences, CeQur Simplicity, SteadyMed Therapeutics and Napo Pharmaceuticals.
Is Kingdon Capital a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDrug DiscoveryMedTechPharmaPost-IPO Equity
Contacts
Who to pitch at Kingdon Capital
Kingdon Capital portfolio companies (9)
- Jasper Therapeutics
- Shoreline Biosciences
- Imago BioSciences
- CeQur Simplicity
- SteadyMed Therapeutics
- Napo Pharmaceuticals
- Sapience Therapeutics
- enVVeno Medical Corporation
- Athenex
Co-investors
Funds that share portfolio companies with Kingdon Capital.
Similar funds
Showing 20 of 100
About Kingdon Capital
The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, MedTech and Pharma; known deals cluster at Growth, Late-Stage and Series B.
The team counts 4 people in our database. Kathleen Kelley (Portfolio Manager), Steven Grinfeld (Investor) and Wendy Chen (Investor) are shown as the contacts to pitch.
Kingdon Capital shares portfolio companies with 14 other investment firms, among them Federated Hermes, Metalmark Capital and Xeraya Capital.
Frequently asked questions
What is Kingdon Capital?
Kingdon Capital is a venture debt provider whose team is concentrated in New York, United States, with a known portfolio of 9 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Kingdon Capital invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, MedTech and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Kingdon Capital invest at?
The known deals of Kingdon Capital include Growth, Late-Stage and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Kingdon Capital?
3 of the 4 people on file at Kingdon Capital are listed as contacts for the firm. All 4 have their own profile page.
How do I contact Kingdon Capital?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 4 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal